EKO Health
↗Emeryville, California, USA
EKO Health is a leading AI-powered digital health company specializing in cardiovascular and pulmonary disease detection. The company develops FDA-cleared software platforms and hardware (digital stethoscopes) that combine clinical-grade ECG, digital auscultation, and artificial intelligence to detect and monitor heart and lung diseases. The SENSORA platform uses machine learning foundation models to analyze cardiac sounds and ECG signals simultaneously, enabling detection of atrial fibrillation, heart murmurs, low ejection fraction (heart failure), and pulmonary hypertension. EKO's technology is designed for use across healthcare settings including primary care, cardiology, urgent care, and telehealth, with over 650,000 devices deployed globally. The company has strong academic and health system partnerships including Mayo Clinic, Northwestern Medicine, and UCSF, and was recognized as one of TIME magazine's World's Top HealthTech Companies in 2025.
CLASSIFICATION
Company Type:MedTech
Therapeutic Areas:-
Industry:Digital Health / Medical Devices / Diagnostics
Sub-Industry:Cardiac AI, Digital Stethoscopes, Pulmonary Diagnostics
SIZE & FINANCIALS
Employees:51-200
Founded:2013
Ownership:private
Status:operating
FUNDING
Stage:Series D
Total Raised:$165M+
Investors:Highland Capital Partners, Questa Capital, Artis Ventures, DigiTx Partners, NTTVC, Morningside Technology Ventures Limited, Mayo Clinic, Sutter Health, Double Point Ventures, EDBI (Singapore Economic Development Board), LG Technology Ventures
PIPELINE
Stage:Commercial
Lead Drug Stage:SENSORA platform (commercially available, FDA-cleared)
Modalities:AI Algorithms, Digital Stethoscopes, ECG (3-lead), Machine Learning Foundation Models, Acoustic Analysis
Active Trials:3
Trial Phases:Phase 2: 1 | Phase 3: 2
FDA Approvals:4
CORPORATE STRUCTURE
Key Partnerships:Mayo Clinic - AI-enabled low ejection fraction detection algorithm development and clinical validation, Northwestern Medicine - Valvular heart disease screening and structural heart disease research, UCSF - Clinical research partnerships, Littmann (3M) - Digital stethoscope co-development and distribution
COMPETITION
Position:Leader
Competitors:Littmann (3M) - Traditional and digital stethoscopes, GE HealthCare - Cardiac imaging and diagnostics, Siemens Healthineers - Medical imaging and diagnostics, Medtronic - Cardiac monitoring devices, Philips - Healthcare monitoring solutions
LEADERSHIP
Key Executives:
Connor Landgraf - Co-Founder & CEO
Jason Bellet - Co-Founder & Chief Business Officer
Tyler Crouch - Co-Founder & Head of Education Product
Jerome Adams - Distinguished Medical Advisor
Stefan Jarschel - VP of Software Engineering
Kumar Iyer - Chief Product Officer
Scientific Founders:Connor Landgraf - Bioengineering background, UC Berkeley
LINKS
⚠
Is this information incorrect? This profile was AI-generated from publicly available sources and may contain errors. If you are a representative of EKO Health and believe any information on this page is inaccurate, we will promptly correct or remove it.REPORT AN ERROR
Disclaimer: IntuitionLabs.ai is not affiliated with, endorsed by, or associated with EKO Health. The information on this page was compiled using AI from publicly available sources and may be incomplete, outdated, or contain errors. We are committed to correcting inaccuracies promptly upon notice. For official information, please visit the company's website directly.